28 Tabs — 30 mg
Mimpara is a medication used to treat secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease on dialysis. It can also be used to treat calcium and phosphorus levels in people with SHPT who are not on dialysis.
Mimpara (generic name cinacalcet) is a medication primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, and hypercalcemia in patients with parathyroid carcinoma. It works by decreasing the levels of parathyroid hormone (PTH), calcium, and phosphorus in the body. Mimpara belongs to a class of drugs known as calcimimetics. It helps to regulate the body's production of calcium and phosphorus, essential minerals for bone health.
It's important to follow your healthcare provider's instructions on dosage and frequency. Potential side effects may include nausea, vomiting, and dizziness. Always consult a healthcare professional for personalized advice.